https://imedsciences.com/ editor_ijims@hotmail.com
ISSN: 2394-4137 (E) 2394-6318 (P)

IJIMS.2019.116

Type of Article: Original Research

Volume 6; Issue 4: 2019

Page No.: 830-834

DOI: 10.16965/ijims.2019.116

A COMPARATIVE STUDY OF EFFICACY OF TOPICAL DIFLUPREDNATE OPHTHALMIC EMULSION 0.05% EYE DROPS WITH BETAMETHASONE SUSPENSION 0.1% IN POSTOPERATIVE SMALL INCISION CATARACT SURGERY

Srividya R 1, H. Siddesh Kumar *2.

1 Junior resident in dept. of ophthalmology, RIMS, Raichur, Karnataka, India.

*2 Associate professor in dept. of ophthalmology, RIMS, Raichur, Karnataka, India.

Corresponding author: Dr. H. Siddesh Kumar, Associate professor in dept. of ophthalmology, RIMS, Raichur, Karnataka, India. E-Mail: drsiddesh@gmail.com, srividyador@gmail.com

ABSTRACT:

Postoperative operative inflammation following cataract surgery is common occurrence may be due to several surgery-dependent factors such as surgical trauma, intraocular lens type, and due to various physical, chemical and biological agents introduced during surgery and also on patient-dependent factors such as history of inflammatory disease and degree of iris pigmentation. Anti-inflammatory agents are routinely prescribed following cataract extraction surgery to resolve signs and symptoms of inflammation more rapidly and to improve patient comfort. For the treatment of postoperative ocular inflammation and pain the most widely prescribed topical corticosteroid is betamethasone 0.1%, and Difluprednate ophthalmic emulsion 0.05% a strong topical steroid. Hence, this study was to compare the efficacy and safety of topical corticosteroids- Difluprednate 0.05% and betamethasone 0.1%, in managing inflammation and pain following post cataract extraction surgery. In a total 100 patients were randomized into two groups Group –A (50 patients) prescribing topical Difluprednate emulsion 0.05% and Group-B (50 patients) prescribing betamethasone phosphate 0.1%.  in our observation after 15 days no pain in group-A, after 30 days no one are having corneal oedema in group-A. Difluprednate emulsion 0.05% drug was efficient in the reduction of anterior chamber cells and flare with betamethasone phosphate 0.1% being more rapid.  Based on our findings and previous study results, Difluprednate emulsion 0.05% can be used in post-operative management post cataract surgery, however, further clinical trials with long follow- up periods are required.

Key words: Betamethasone Phosphate, Cataract Surgery, Difluprednate Emulsion, Inflammation and Pain.

REFERENCES

  1. El-Harazi SM, Feldman RM. Control of intra-ocular inflammation associated with cataract surgery. Curr Opin Ophthalmol 2001; 12(1):4–8.
  2. Donnenfeld ED. Difluprednate for the prevention of ocular inflammation postsurgery: an update. Clin Ophthalmol 2011; 5:811–6.
  3. Smith S, Lorenz D, Peace J, McLeod K, Crockett RS, Vogel R. Difluprednate ophthalmic emulsion 0.05% (Durezol) administered two times daily for managing ocular inflammation and pain following cataract surgery. Clin Ophthalmol. 2010;4:983-91.
  4. Stringer W, Bryant R. Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%. Clin Ophthalmol. 2010;4:1119–24.
  5. Korenfeld MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS. Difluprednate Ophthalmic Emulsion 0.05% (Durezol) Study Group. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg. 2009;35(1):26-34.
  6. Foster CS, Davanzo R, Flynn TE, McLeod K,  Vogel R,  Crockett RS. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. J Ocul Pharmacol Ther. 2010; 26(5):475-83.
  7. Donnenfeld ED, Holland EJ, Solomon KD, Fiore J, Gobbo A, Prince J, et al. A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery. Am J Ophthalmol. 2011; 152(4):609-17.
  8. Reddy R, Patil A. Comparative study of efficacy of topical dexamethasone 0.1% with difluprednate 0.05% in post-operative small incision cataract surgery. Ind J Clin Exp Ophthalmol. 2018;4(3):339-46.

Download Full Text TOC